By Martin Bricketto ( December 20, 2011, 9:12 PM EST) -- New Jersey-based C.R. Bard Inc. will acquire fellow medical device company Lutonix Inc. for as much as $325 million to tap into an arterial disease treatment Lutonix has been developing, Bard announced Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.